Graft Versus Host Disease (GvHD) Latest Advances

Find the Latest Research About Graft Versus Host Disease (GvHD)

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33043 publications

Pulmonary complications in pediatric hematopoietic stem cell transplantation: an overview for pediatricians.

Pulmonary complications in pediatric hematopoietic stem cell transplantation: an overview for pediatricians.

Journal: Current opinion in pediatrics
Published: April 15, 2026

The end of 'leaky gut': pathway-specific mechanistic approaches to barrier restoration.

The end of 'leaky gut': pathway-specific mechanistic approaches to barrier restoration.

Journal: Current opinion in gastroenterology
Published: April 13, 2026

Relation between sirtuin-1 activity and graft-versus-host disease (GVHD) status post allogeneic haematopoietic stem-cell transplantation (HSCT): Prospective study.

Relation between sirtuin-1 activity and graft-versus-host disease (GVHD) status post allogeneic haematopoietic stem-cell transplantation (HSCT): Prospective study.

Journal: The Egyptian journal of immunology
Published: April 12, 2026

Role of Cannabinoid Receptor Type 2 in Acute Behavioral Responses to Graft Versus Host Disease in Male Mice.

Role of Cannabinoid Receptor Type 2 in Acute Behavioral Responses to Graft Versus Host Disease in Male Mice.

Journal: Cannabis and cannabinoid research
Published: April 10, 2026

The anti-inflammatory effects of mesenchymal stem cells and their research progress in hematopoietic stem cell transplantation: A comprehensive review.

The anti-inflammatory effects of mesenchymal stem cells and their research progress in hematopoietic stem cell transplantation: A comprehensive review.

Journal: Cell transplantation
Published: April 10, 2026

Corticosteroid resistance is predetermined by early immune response dynamics at acute graft-versus-host disease onset.

Corticosteroid resistance is predetermined by early immune response dynamics at acute graft-versus-host disease onset.

Journal: Science translational medicine
Published: April 08, 2026

"Assessing Long-Term Health-Related Quality of Life in Children with β-Thalassemia Major Following Hematopoietic Stem Cell Transplantation" - A Cross-Sectional Comparative Study.

"Assessing Long-Term Health-Related Quality of Life in Children with β-Thalassemia Major Following Hematopoietic Stem Cell Transplantation" - A Cross-Sectional Comparative Study.

Journal: Hemoglobin
Published: April 07, 2026

First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia.

First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 06, 2026

Umbilical cord-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a real-world study.

Umbilical cord-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a real-world study.

Journal: Leukemia & lymphoma
Published: April 01, 2026

HSR26-227: Post-Allogenic Hematopoietic Stem Cell Transplant (Allo-HSCT), Hypomethylating-Agent Maintenance Improves Survival Without Increasing GVHD (Graft Versus Host Disease) in AML/MDS (Acute Myeloid Leukemia/Myelodysplastic Syndrome): Updated Systematic Review and Meta-Analysis.

HSR26-227: Post-Allogenic Hematopoietic Stem Cell Transplant (Allo-HSCT), Hypomethylating-Agent Maintenance Improves Survival Without Increasing GVHD (Graft Versus Host Disease) in AML/MDS (Acute Myeloid Leukemia/Myelodysplastic Syndrome): Updated Systematic Review and Meta-Analysis.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026

Correction: Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease.

Correction: Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease.

Journal: Bone marrow transplantation
Published: March 30, 2026

Allogeneic Hematopoietic Cell Transplantation for Relapsed / Refractory Hodgkin Lymphoma: A Multicenter Real-World Experience.

Allogeneic Hematopoietic Cell Transplantation for Relapsed / Refractory Hodgkin Lymphoma: A Multicenter Real-World Experience.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: March 26, 2026
Showing 1-12 of 33,043

Last Updated: 04/28/2026